Digital devices useful in visual rehabilitation

Article

Digital devices may be used as a visual rehabilitation technique for low-vision AMD patients, according to a paper featured in the journal Eye.

Digital devices may be used as a visual rehabilitation technique for low-vision AMD patients, according to a paper featured in the journal Eye.

An investigation led by Dr K. Gill, Department of Ophthalmology, University of Western Ontario, London, Ontario, Canada, included 27 patients in the study. All patients had stable wet AMD in one or both eyes and were assessed for reading speeds on both digital readers and standard paper text.

The reading speed was calculated as words per minute and each patient completed the visual analogue scale after reading each passage. The patients read font sizes ranged from newsprint to large print books and then read from digital devices for comparison.

In conclusion, patients read faster on the Apple iPad with text sizes of 24 or more, compared to paper. Patients claimed the digital device has the best clarity but the print paper is the easiest to use.

Devices with larger display screens and high contrast ratios are beneficial to AMD patients who require larger texts for reading.

The abstract can be found here.

Related Videos
ARVO 2024: Andrew D. Pucker, OD, PhD on measuring meibomian gland morphology with increased accuracy
 Allen Ho, MD, presented a paper on the 12 month results of a mutation agnostic optogenetic programme for patients with severe vision loss from retinitis pigmentosa
Noel Brennan, MScOptom, PhD, a clinical research fellow at Johnson and Johnson
ARVO 2024: President-elect SriniVas Sadda, MD, speaks with David Hutton of Ophthalmology Times
Elias Kahan, MD, a clinical research fellow and incoming PGY1 resident at NYU
Neda Gioia, OD, sat down to discuss a poster from this year's ARVO meeting held in Seattle, Washington
Eric Donnenfeld, MD, a corneal, cataract and refractive surgeon at Ophthalmic Consultants of Connecticut, discusses his ARVO presentation with Ophthalmology Times
John D Sheppard, MD, MSc, FACs, speaks with David Hutton of Ophthalmology Times
Paul Kayne, PhD, on assessing melanocortin receptors in the ocular space
Osamah Saeedi, MD, MS, at ARVO 2024
© 2024 MJH Life Sciences

All rights reserved.